Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Self-reported issues with driving in patients with chronic pain.

Fan A, Wilson KG, Acharya M, Cranney A, Buenger U, Marshall S.

PM R. 2012 Feb;4(2):87-95. doi: 10.1016/j.pmrj.2011.10.008.

PMID:
22264800
2.

Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada.

Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, Atkinson SA, Josse RG, Feldman S, Kline GA, Rosen C; Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada..

CMAJ. 2010 Sep 7;182(12):E610-8. doi: 10.1503/cmaj.080663. Review. No abstract available.

3.

Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary).

Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD; Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada..

CMAJ. 2010 Sep 7;182(12):1315-9. doi: 10.1503/cmaj.091062. Review. No abstract available.

4.

Supporting safe driving with arthritis: developing a driving toolkit for clinical practice and consumer use.

Vrkljan BH, Cranney A, Worswick J, O'Donnell S, Li LC, GĂ©linas I, Byszewski A, Man-Son-Hing M, Marshall S.

Am J Occup Ther. 2010 Mar-Apr;64(2):259-67.

PMID:
20437913
5.

Osteoporosis knowledge among individuals with recent fragility fracture.

Giangregorio L, Thabane L, Cranney A, Adili A, deBeer J, Dolovich L, Adachi JD, Papaioannou A.

Orthop Nurs. 2010 Mar-Apr;29(2):99-107. doi: 10.1097/NOR.0b013e3181d2436c.

6.

A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents.

Sawka AM, Ismaila N, Cranney A, Thabane L, Kastner M, Gafni A, Woodhouse LJ, Crilly R, Cheung AM, Adachi JD, Josse RG, Papaioannou A.

PLoS One. 2010 Mar 3;5(3):e9515. doi: 10.1371/journal.pone.0009515. Review.

7.

Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA.

Sambrook P, Cranney A, Adachi JD.

Curr Med Res Opin. 2010 Mar;26(3):599-604. doi: 10.1185/03007990903512321.

PMID:
20055751
8.

Acute monoarthritis: what is the cause of my patient's painful swollen joint?

Ma L, Cranney A, Holroyd-Leduc JM.

CMAJ. 2009 Jan 6;180(1):59-65. doi: 10.1503/cmaj.080183. Review. No abstract available.

9.

Factors predicting osteoporosis treatment initiation in a regionally based cohort.

Cranney A, Tsang JF, Leslie WD.

Osteoporos Int. 2009 Sep;20(9):1621-5. doi: 10.1007/s00198-008-0823-8.

PMID:
19096744
10.

Efficacy of food fortification on serum 25-hydroxyvitamin D concentrations: systematic review.

O'Donnell S, Cranney A, Horsley T, Weiler HA, Atkinson SA, Hanley DA, Ooi DS, Ward L, Barrowman N, Fang M, Sampson M, Tsertsvadze A, Yazdi F.

Am J Clin Nutr. 2008 Dec;88(6):1528-34. doi: 10.3945/ajcn.2008.26415. Review.

11.

Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls.

O'Donnell S, Moher D, Thomas K, Hanley DA, Cranney A.

J Bone Miner Metab. 2008;26(6):531-42. doi: 10.1007/s00774-008-0868-y. Review.

PMID:
18979152
12.

Osteoporosis risk perceptions among patients who have sustained a fragility fracture.

Giangregorio L, Dolovich L, Cranney A, Adili A, Debeer J, Papaioannou A, Thabane L, Adachi JD.

Patient Educ Couns. 2009 Feb;74(2):213-20. doi: 10.1016/j.pec.2008.08.001.

13.

Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.

Moayyedi P, Cranney A.

Am J Gastroenterol. 2008 Oct;103(10):2428-31. doi: 10.1111/j.1572-0241.2008.02031.x. Review.

PMID:
18855852
14.

Risk factors for low BMD in healthy men age 50 years or older: a systematic review.

Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O'Brien CJ, Sawka AM, Khan A, Siminoski K, Tarulli G, Webster D, McGowan J, Adachi JD.

Osteoporos Int. 2009 Apr;20(4):507-18. doi: 10.1007/s00198-008-0720-1. Review.

15.

Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health.

Cranney A, Weiler HA, O'Donnell S, Puil L.

Am J Clin Nutr. 2008 Aug;88(2):513S-519S. Review.

16.

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.

Cranney A, Wells GA, Yetisir E, Adami S, Cooper C, Delmas PD, Miller PD, Papapoulos S, Reginster JY, Sambrook PN, Silverman S, Siris E, Adachi JD.

Osteoporos Int. 2009 Feb;20(2):291-7. doi: 10.1007/s00198-008-0653-8.

PMID:
18663402
17.

A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial.

Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM, Harrison MB, Anastassiades T, Grimshaw JM, Graham ID.

Osteoporos Int. 2008 Dec;19(12):1733-40. doi: 10.1007/s00198-008-0669-0.

PMID:
18629567
18.

Do patients perceive a link between a fragility fracture and osteoporosis?

Giangregorio L, Papaioannou A, Thabane L, DeBeer J, Cranney A, Dolovich L, Adili A, Adachi JD.

BMC Musculoskelet Disord. 2008 Mar 21;9:38. doi: 10.1186/1471-2474-9-38.

19.

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004523. doi: 10.1002/14651858.CD004523.pub3. Review.

PMID:
18254053
20.

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003376. doi: 10.1002/14651858.CD003376.pub3. Review.

PMID:
18254018
Items per page

Supplemental Content

Loading ...
Support Center